Advertisement
Screener

SOLIGENIX, INC. (SNGX) Adjustments to Additional Paid in Capital, Warrant Issued

1.3 / 5 stars · 25/96 Roast Me

SOLIGENIX, INC. Adjustments to Additional Paid in Capital, Warrant Issued

SOLIGENIX, INC. (SNGX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $7.18 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-31

  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-12-31 was $0.00.
  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $7.18M.
  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-12-31 was $28.00, a 99.98% decline year-over-year.
  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $0.00.
  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $7.18M.
  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $79.00, a 99.99% decline from fiscal 2020.
  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $860.92K.
  • SOLIGENIX, INC. adjustments to additional paid in capital, warrant issued for fiscal 2013 was -$4.83M.
Period endAdjustments to Additional Paid in Capital, Warrant Issued 3 monthAdjustments to Additional Paid in Capital, Warrant Issued 6 monthAdjustments to Additional Paid in Capital, Warrant Issued 9 monthAdjustments to Additional Paid in Capital, Warrant Issued 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$7.18M
derived: sum of 2 quarters · filed 2026-03-31
$7.18M
10-K · filed 2026-03-31
2024-09-30$7.18M
10-Q · filed 2025-11-07
$7.18M
10-Q · filed 2025-11-07
2021-12-31$28.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$28.00
derived: sum of 2 quarters · filed 2022-03-29
$79.00
10-K · filed 2022-03-29
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$51.00
10-Q · filed 2021-11-12
2021-06-30$51.00
10-Q · filed 2021-08-13
2020-12-31$175.53K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$175.53K
derived: sum of 2 quarters · filed 2022-03-29
$860.92K
10-K · filed 2022-03-29
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$685.38K
10-Q · filed 2021-11-12
2020-06-30$685.38K
10-Q · filed 2021-08-13
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
-$299.53K
derived: sum of 2 quarters · filed 2015-03-25
-$4.83M
10-K · filed 2015-03-25
2013-09-30-$299.53K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$4.83M
10-Q · filed 2013-11-12
2013-06-30-$4.53M
10-Q · filed 2013-08-12
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27
$0.00
derived: sum of 2 quarters · filed 2012-03-27
$11.18K
10-K · filed 2012-03-27
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$11.18K
10-Q · filed 2011-11-14
2011-06-30$11.18K
10-Q · filed 2011-08-12
2010-12-31$67.05K
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Imunon, Inc. (IMNN)United States$0.008B-0.56
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97